Benzinga | Aug 17, 2021 06:27AM EDT

HC Wainwright & Co. Maintains Buy on Forma Therapeutics Hldgs, Lowers Price Target to $53

HC Wainwright & Co. analyst Robert Burns maintains Forma Therapeutics Hldgs (NASDAQ:FMTX) with a Buy and lowers the price target from $55 to $53.